GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sumitomo Pharma Co Ltd (OTCPK:DNPUF) » Definitions » Operating Margin %

Sumitomo Pharma Co (Sumitomo Pharma Co) Operating Margin % : -37.93% (As of Dec. 2023)


View and export this data going back to 2009. Start your Free Trial

What is Sumitomo Pharma Co Operating Margin %?

Operating Margin % is calculated as Operating Income divided by its Revenue. Sumitomo Pharma Co's Operating Income for the three months ended in Dec. 2023 was $-217 Mil. Sumitomo Pharma Co's Revenue for the three months ended in Dec. 2023 was $572 Mil. Therefore, Sumitomo Pharma Co's Operating Margin % for the quarter that ended in Dec. 2023 was -37.93%.

The historical rank and industry rank for Sumitomo Pharma Co's Operating Margin % or its related term are showing as below:

DNPUF' s Operating Margin % Range Over the Past 10 Years
Min: -53.57   Med: 10.82   Max: 18.89
Current: -53.57


DNPUF's Operating Margin % is ranked worse than
83.14% of 1020 companies
in the Drug Manufacturers industry
Industry Median: 6.385 vs DNPUF: -53.57

Sumitomo Pharma Co's 5-Year Average Operating Margin % Growth Rate was 0.00% per year.

Sumitomo Pharma Co's Operating Income for the three months ended in Dec. 2023 was $-217 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Dec. 2023 was $-1,261 Mil.


Sumitomo Pharma Co Operating Margin % Historical Data

The historical data trend for Sumitomo Pharma Co's Operating Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sumitomo Pharma Co Operating Margin % Chart

Sumitomo Pharma Co Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Operating Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 12.60 17.24 13.80 10.76 -13.86

Sumitomo Pharma Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Operating Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.90 -62.14 -68.13 -45.39 -37.93

Competitive Comparison of Sumitomo Pharma Co's Operating Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Sumitomo Pharma Co's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sumitomo Pharma Co's Operating Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Sumitomo Pharma Co's Operating Margin % distribution charts can be found below:

* The bar in red indicates where Sumitomo Pharma Co's Operating Margin % falls into.



Sumitomo Pharma Co Operating Margin % Calculation

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

Sumitomo Pharma Co's Operating Margin % for the fiscal year that ended in Mar. 2023 is calculated as

Operating Margin %=Operating Income (A: Mar. 2023 ) / Revenue (A: Mar. 2023 )
=-575.913 / 4156.263
=-13.86 %

Sumitomo Pharma Co's Operating Margin % for the quarter that ended in Dec. 2023 is calculated as

Operating Margin %=Operating Income (Q: Dec. 2023 ) / Revenue (Q: Dec. 2023 )
=-217.021 / 572.199
=-37.93 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sumitomo Pharma Co  (OTCPK:DNPUF) Operating Margin % Explanation

Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.


Be Aware

Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia’s Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


Sumitomo Pharma Co Operating Margin % Related Terms

Thank you for viewing the detailed overview of Sumitomo Pharma Co's Operating Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Sumitomo Pharma Co (Sumitomo Pharma Co) Business Description

Traded in Other Exchanges
Address
6-8, Doshomachi 2-chome, Chuo-ku, Osaka, JPN, 541-0045
Sumitomo Pharma Co Ltd is a specialty and generic drug manufacturing company. Sumitomo's vast majority of sales are generated in North America, followed by Japan. The company's core business is its pharmaceutical products business. The pharmaceutical business maintains a focus on a variety of areas, including cardiovascular/diabetes, psychiatry & neurology, and specialty areas. Sumitomo considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.